Abstract
Purpose
We aimed to construct novel nomograms for nodal and distant metastasis for patients with G1 and G2 colorectal neuroendocrine tumors (NETs).
Methods
A training set and validation set were obtained by including G1 and G2 colorectal NET patients from the Surveillance, Epidemiology, and End Results database and the Cancer Hospital Chinese Academy of Medical Science, respectively. The area under curve (AUC) values under receiver operating characteristic (ROC) curves, calibration plots, and the Hosmer‒Lemeshow tests were used to evaluate the discriminability and calibration of nomograms.
Results
In total, 3690 and 172 patients were included in the training set and validation set, respectively. Tumor size, location, and T stage were included in the nomogram predicting nodal metastasis. The AUC values of the nomogram were 0.972 (95% confidence interval (CI): 0.964–0.980) and 0.897 (95% CI: 0.846–0.948) in the training set and validation set, respectively. The calibration plots and Hosmer‒Lemeshow test for the training set (P = 0.999) and validation set (P = 0.537) showed good model calibration. Tumor size, T stage, and N stage were incorporated into the nomogram predicting distant metastasis. The ROC curves demonstrated desirable discrimination both in the training set (AUC = 0.938 (95% CI: 0.921–0.954)) and validation set (AUC = 0.938 (95% CI: 0.890–0.988)). The calibration curves and Hosmer‒Lemeshow test indicated acceptable model calibration both in the training set (P = 0.908) and validation set (P = 0.722).
Conclusion
The proposed nomograms may be used as a reliable tool to predict the nodal and distant metastasis in G1 and G2 colorectal NETs.
Similar content being viewed by others
Data availability
The data used to support the findings of this study are available from the corresponding author upon request.
References
Kooyker AI, Verbeek WH, van den Berg JG, Tesselaar ME, van Leerdam ME (2020) Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade. United Eur Gastroenterol J 8:59–67. https://doi.org/10.1177/2050640619865113
Hrabe J (2020) Neuroendocrine tumors of the appendix, colon, and rectum. Surg Oncol Clin N Am 29:267–279. https://doi.org/10.1016/j.soc.2019.11.010
Abdel-Rahman O (2021) Characterization of a novel entity of G3 (high-grade well-differentiated) colorectal neuroendocrine tumors (NET) in the SEER database. Am J Clin Oncol 44:43. https://doi.org/10.1097/COC.0000000000000777
Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F et al (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 95:88–97. https://doi.org/10.1159/000335594
Xiao K, Zhao Y, Cai Y, Chen P, Chen J, Ye R et al (2020) The effect of marital status on the survival of patients with colorectal neuroendocrine neoplasms: an analysis of the SEER database. Rev Esp Enferm Dig 112:109–117. https://doi.org/10.17235/reed.2019.6183/2019
Ding X, Tian S, Hu J, Wang G, Yu X, Fu D et al (2021) Risk and prognostic nomograms for colorectal neuroendocrine neoplasm with liver metastasis: a population-based study. Int J Colorectal Dis 36:1915–1927. https://doi.org/10.1007/s00384-021-03920-y
Zhu H, Zhao S, Zhang C, Ji K, Wu W, Yin L et al (2021) Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study. Surg Endosc. https://doi.org/10.1007/s00464-021-08535-6
Folkert IW, Sinnamon AJ, Concors SJ, Bennett BJ, Fraker DL, Mahmoud NN et al (2020) Grade is a dominant risk factor for metastasis in patients with rectal neuroendocrine tumors. Ann Surg Oncol 27:855–863. https://doi.org/10.1245/s10434-019-07848-0
Li YW, He YP, Liu FQ, Peng JJ, Cai SJ, Xu Y et al (2021) Grade G2 rectal neuroendocrine tumor is much more invasive compared with G1 tumor. Front Oncol 11:646536. https://doi.org/10.3389/fonc.2021.646536
Sekiguchi M, Hotta K, Takeuchi Y, Tanaka S, Yamamoto H, Shinmura K et al (2022) Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY. J Gastroenterol 57:547–558. https://doi.org/10.1007/s00535-022-01877-5
Yamaguchi T, Takahashi K, Yamada K, Bando H, Baba H, Ito M et al (2021) A nationwide, multi-institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan. Ann Gastroenterol Surg 5:215–220. https://doi.org/10.1002/ags3.12403
Yan L, Xu Y, Pan J, Bai J, Long Q, He N et al (2022) Prognostic evaluation of patients with rectal neuroendocrine neoplasms and hepatic metastases: a SEER database analysis. J Oncol 2022:2451282. https://doi.org/10.1155/2022/2451282
Ushigome H, Fukunaga Y, Nagasaki T, Akiyoshi T, Konishi T, Fujimoto Y et al (2019) Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors. PLoS One 14:e0211675. https://doi.org/10.1371/journal.pone.0211675
Kim BC, Kim YE, Chang HJ, Lee SH, Youk EG, Lee DS et al (2016) Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumours. Colorectal Dis 18:O243-251. https://doi.org/10.1111/codi.13377
Zhou Z, Wang Z, Zhang B, Wu Y, Li G and Wang Z (2021) Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT scans in the evaluation of primary tumors and lymph node metastasis in patients with rectal neuroendocrine tumors. Front Endocrinol (Lausanne) 12:727327. https://doi.org/10.3389/fendo.2021.727327
Chida K, Watanabe J, Hirasawa K, Inayama Y, Misumi T, Kunisaki C et al (2020) A novel risk-scoring system for predicting lymph node metastasis of rectal neuroendocrine tumors. Ann Gastroenterol Surg 4:562–570. https://doi.org/10.1002/ags3.12355
Gamboa AC, Liu Y, Lee RM, Zaidi MY, Staley CA, Russell MC et al (2019) A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique. J Surg Oncol 120:932–939. https://doi.org/10.1002/jso.25679
Chen Q, Chen J, Deng Y, Zhang Y, Huang Z, Zhao H et al (2022) Nomogram for the prediction of lymph node metastasis and survival outcomes in rectal neuroendocrine tumour patients undergoing resection. J Gastrointest Oncol 13:171–184. https://doi.org/10.21037/jgo-21-573.
Nam SJ, Kim BC, Chang HJ, Jeon HH, Kim J, Kim SY (2022) Risk factors for lymph node metastasis and oncologic outcomes in small rectal neuroendocrine tumors with lymphovascular invasion. Gut Liver 16:228–235. https://doi.org/10.5009/gnl20364
Park SB, Kim DJ, Kim HW, Choi CW, Kang DH, Kim SJ et al (2017) Is endoscopic ultrasonography essential for endoscopic resection of small rectal neuroendocrine tumors? World J Gastroenterol 23:2037–2043. https://doi.org/10.3748/wjg.v23.i11.2037
Chen L, Guo Y, Zhang Y, Liu M, Zhang Y, Lin Y et al (2021) Development of a novel scoring system based on endoscopic appearance for management of rectal neuroendocrine tumors. Endoscopy 53:702–709. https://doi.org/10.1055/a-1274-0161
Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA et al (2013) Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 42:557–577. https://doi.org/10.1097/MPA.0b013e31828e34a4
Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O’Dorisio TM, Warner RR et al (2010) The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 39:767–774. https://doi.org/10.1097/MPA.0b013e3181ec1261
Clark OH, Benson AB 3rd, Berlin JD, Choti MA, Doherty GM, Engstrom PF et al (2009) NCCN clinical practice guidelines in oncology: neuroendocrine tumors. J Natl Compr Canc Netw 7:712–747. https://doi.org/10.6004/jnccn.2009.0050
Funding
This study was supported by the following grants: the National Key Research and Development Program (No. 2022YFC2505003) and the Special Fund of China Cancer Research Foundation/Beijing Hope Marathon (No. LC2017L03).
Author information
Authors and Affiliations
Contributions
Wang Zhijie collected and analyzed the data and drafted this manuscript. Qian Liu designed this study and reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Z., Liu, Q. Development of novel prediction models for nodal and distant metastasis in G1 and G2 colorectal neuroendocrine tumors. Int J Colorectal Dis 38, 37 (2023). https://doi.org/10.1007/s00384-023-04331-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s00384-023-04331-x